Analysts expect over 2021 decreasing revenue Merck & Co, relatively high dividend

Tomorrow the American company Merck KGaA & Co will publish its past quarter results. For this year the company from Kenilworth could earn a total revenue around 46.24 billion USD. This is according to the average of the analysts' estimates. This is slightly lower than 2021's revenue of 47.99 billion USD.

Historical revenues and results Merck KGaA & Co plus estimates 2021

The analysts expect for 2021 a net profit of 14.05 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 5.52 USD. Based on this the price/earnings-ratio is 14.1.

Huge dividend Merck KGaA & Co

For this year the analysts expect a dividend of 2.52 USD per share. The dividend yield is then 3.24 percent. The average dividend yield of the pharmaceutical companies equals an attractive 1.52 percent.

Latest estimates around 126 USD

The most recent recommendations for the pharmaceutical company are from Barclays , ABN AMRO and HSBC .

Merck KGaA & Co's market capitalization is based on the number of outstanding shares around 197.66 billion USD. 6

Historical stock prices Merck KGaA & Co

On Tuesday, the stock closed at 77.85 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.